Carter, Ronald F. “Do You Believe That N-of-1 Trials (a Clinical Trial in Which a Single Patient Is the Entire trial), Are Appropriate to Evaluate the Effectiveness of Genomic Therapies for Rare and or Common Genetic Disorders? Do Gene-Editing Targeting Therapies Have the Potential to Expedite the Advancement of Personalized Medicine?”. Health Science Inquiry, vol. 8, no. 1, June 2017, p. Page 60-Page 61, doi:10.29173/hsi223.